A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.
A new animal model can be used to “dissect” the inflammatory response to infection.
Inducing “tolerance” to bacterial toxins in the endothelial cells that line blood vessels may offer a new approach for preventing the negative consequences of sepsis.
Vanderbilt study adds to the mounting role for inflammatory signaling in obesity.
New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs.
Dietary vitamin C may maintain healthy blood vessels in patients with inflammatory diseases.
Accessibility Tools